Design Therapeutics, Inc. (DSGN)
11.65
+0.16
(+1.39%)
USD |
NASDAQ |
Oct 09, 16:00
11.65
0.00 (0.00%)
After-Hours: 20:00
Design Therapeutics EPS Diluted (Quarterly) : -0.3226 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3226 |
| March 31, 2026 | -0.2871 |
| December 31, 2025 | -0.2724 |
| September 30, 2025 | -0.2984 |
| June 30, 2025 | -0.3356 |
| March 31, 2025 | -0.3121 |
| December 31, 2024 | -0.2408 |
| September 30, 2024 | -0.2303 |
| June 30, 2024 | -0.2085 |
| March 31, 2024 | -0.1966 |
| December 31, 2023 | -0.2109 |
| September 30, 2023 | -0.282 |
| June 30, 2023 | -0.3563 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.3451 |
| December 31, 2022 | -0.3104 |
| September 30, 2022 | -0.3174 |
| June 30, 2022 | -0.2694 |
| March 31, 2022 | -0.239 |
| December 31, 2021 | -0.1996 |
| September 30, 2021 | -0.205 |
| June 30, 2021 | -0.1386 |
| March 31, 2021 | -0.1002 |
| September 30, 2020 | -0.0422 |
| June 30, 2020 | -0.0262 |
| March 31, 2020 | -0.0119 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Palvella Therapeutics, Inc. | -1.523 |
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.16M |
| Total Expenses (Quarterly) | 20.16M |
| Enterprise Value | 524.32M |
| Earnings Yield | -10.13% |
| Normalized Earnings Yield | -10.13 |